AC Followed by Pertuzumab/Trastuzumab/Paclitaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide and doxorubicin followed by pertuzumab, trastuzumab, and paclitaxel, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.

**Synonyms:** - AC Followed by Paclitaxel + Pertuzumab + Trastuzumab - AC Followed by Paclitaxel + Trastuzumab + Pertuzumab - AC Followed by Pertuzumab + Trastuzumab + Paclitaxel - AC Followed by Pertuzumab-Trastuzumab-Paclitaxel Regimen - AC-Pertuzumab + Trastuzumab + Paclitaxel - AC-THP (Paclitaxel) (trastuzumab-anns) - AC-THP (Paclitaxel) (trastuzumab-dkst) - AC-THP (Paclitaxel) (trastuzumab-dttb) - AC-THP (Paclitaxel) (trastuzumab-herw) - AC-THP (Paclitaxel) (trastuzumab-pkrb) - AC-THP (Paclitaxel) (trastuzumab-qyyp) - AC-THP (Paclitaxel) (trastuzumab-strf) - AC-THP (Paclitaxel) (trastuzumab-zerc) - Doxorubicin/Cyclophosphamide Followed by Pertuzumab + Trastuzumab + Paclitaxel - Doxorubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Paclitaxel - ddAC-THP (Paclitaxel)